Thr613

Site Information
ERIIKsItPEtPTEI SwissProt Entrez-Gene
Blast this site against: NCBI SwissProt PDB
Site Group ID: 7576401

In vivo Characterization
Methods used to characterize site in vivo:	immunoprecipitation ( 2 ) , mass spectrometry ( 1 ) , mutation of modification site ( 2 ) , western blotting ( 2 )
Disease tissue studied:	lung cancer ( 1 ) , non-small cell lung cancer ( 1 )
Relevant cell line - cell type - tissue:	CHO (fibroblast) ( 2 ) , lung ( 1 )

Downstream Regulation
Effects of modification on SERT:	intracellular localization ( 2 ) , molecular association, regulation ( 2 )
Inhibit interaction with:	Vimentin (human) ( 2 )

References
1	Rikova K (2010) CST Curation Set: 9466; Year: 2010; Biosample/Treatment: tissue, lung/untreated; Disease: non-small cell lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY]) Curated Info
2	Ahmed BA, et al. (2009) The cellular distribution of serotonin transporter is impeded on serotonin-altered vimentin network. PLoS One 4, e4730 19270731 Curated Info